Naturally-occurring serotype 3 Streptococcus pneumoniae strains that lack functional pneumolysin and autolysin have attenuated virulence but induce localized protective immune responses.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
Streptococcus pneumoniae is an important cause of fatal pneumonia in humans. These bacteria express virulence factors, such as the toxins pneumolysin and autolysin, that drive host inflammatory responses. In this study we confirm loss of pneumolysin and autolysin function in a group of clonal pneumococci that have a chromosomal deletion resulting in a pneumolysin-autolysin fusion gene Δ(lytA'-ply')593. The Δ(lytA'-ply')593 pneumococci strains naturally occur in horses and infection is associated with mild clinical signs. Here we use immortalized and primary macrophage in vitro models, which include pattern recognition receptor knock-out cells, and a murine acute pneumonia model to show that a Δ(lytA'-ply')593 strain induces cytokine production by cultured macrophages, however, unlike the serotype-matched ply+lytA+ strain, it induces less tumour necrosis factor α (TNFα) and no interleukin-1β production. The TNFα induced by the Δ(lytA'-ply')593 strain requires MyD88 but, in contrast to the ply+lytA+ strain, is not reduced in cells lacking TLR2, 4 or 9. In comparison to the ply+lytA+ strain in a mouse model of acute pneumonia, infection with the Δ(lytA'-ply')593 strain resulted in less severe lung pathology, comparable levels of interleukin-1α, but minimal release of other pro-inflammatory cytokines, including interferon-γ, interleukin-6 and TNFα. These results suggest a mechanism by which a naturally occurring Δ(lytA'-ply')593 mutant strain of S. pneumoniae that resides in a non-human host has reduced inflammatory and invasive capacity compared to a human S. pneumoniae strain. These data probably explain the relatively mild clinical disease in response to S. pneumoniae infection seen in horses in comparison to humans.
Description
Acknowledgements: The pneumococcal strains isolated from horses were generously provided by Dr. Andrew Waller (Animal Health Trust, UK). Immortalised murine bone marrow-derived macrophages (iBMDM) were a gift from Prof. Douglas Golenbock (University of Massachusetts, USA). PRR knock-out mouse strains were a kind gift from Prof. Shizuo Akira (Osaka University, Japan) and Prof. Kate Fitzgerald (University of Massachusetts, USA). Recombinant pneumolysin was a kind gift from Prof. Aras Kadioglu (University of Liverpool, UK). Parts of this data was presented in oral abstract form at the Association for Veterinary Teaching and Research Work Annual Conference, Edinburgh 2019, and poster abstract at Toll 2015 Targeting Innate Immunity, Spain 2015.
Journal Title
Conference Name
Journal ISSN
1932-6203

